Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
21st Mar 2017 11:00 am RNS Price Monitoring Extension
7th Mar 2017 10:54 am RNS Holding(s) in Company
7th Mar 2017 7:00 am RNS Notice of Full Year Results
3rd Mar 2017 11:02 am RNS Holding(s) in Company
1st Mar 2017 2:05 pm RNS Second Price Monitoring Extn
1st Mar 2017 2:00 pm RNS Price Monitoring Extension
1st Mar 2017 11:35 am RNS Result of Placing & Subscription & Issue of Equity
28th Feb 2017 7:00 am RNS Proposed Placing and Subscription
20th Feb 2017 7:00 am RNS First Patient Recruited in Phase II RAAA Study
9th Feb 2017 7:00 am RNS Faron update for 2017
9th Dec 2016 1:05 pm RNS Notification of Major Interest in Shares
9th Dec 2016 1:00 pm RNS Notification of Major Interest in Shares
5th Dec 2016 7:00 am RNS PDMR Shareholding
21st Nov 2016 7:00 am RNS Grant of options
31st Oct 2016 7:00 am RNS New Application Accepted by Finnish Patent Office
24th Oct 2016 7:00 am RNS First patient recruited in Japanese Ph III trial
7th Oct 2016 1:41 pm RNS Notification of Major Interest in Shares
6th Oct 2016 10:00 am RNS Notification of Major Interest in Shares
5th Oct 2016 5:10 pm RNS Notification of Major Interest in Shares
26th Sep 2016 3:59 pm RNS Director Dealing
21st Sep 2016 11:27 am RNS Raises £8.0 M through a Placing and Subscription
20th Sep 2016 7:00 am RNS Proposed Placing & Subscription to raise £8M
5th Sep 2016 7:00 am RNS Interim Results for six months ended 30 June 2016
10th Aug 2016 7:00 am RNS Faron Pharmaceuticals Notice of Interim Results
25th Jul 2016 7:00 am RNS Faron enters agreement with Abzena for Clevegen
22nd Jun 2016 12:00 pm RNS Faron to Present at Proactive Investors Forum
14th Jun 2016 7:00 am RNS Faron Provides Update at R&D Day
13th Jun 2016 7:00 am RNS Faron Licenses Traumakine Rights to Pharmbio Korea
26th May 2016 10:53 am RNS Faron Result of Annual General Meeting
26th May 2016 7:00 am RNS Faron Expands R&D Strategy for Clevegen
13th May 2016 7:00 am RNS Faron Pharmaceuticals Ltd to host an R&D Day
4th May 2016 7:00 am RNS Notice of AGM
3rd May 2016 7:00 am RNS Faron Appoints New Medical Director
22nd Apr 2016 7:00 am RNS Faron Appoints Panmure Gordon as Joint Broker
19th Apr 2016 7:00 am RNS Faron Files Two New Patents to Protect Clevegen
10th Mar 2016 7:00 am RNS Annual Results for the year ended 31 December 2015
1st Mar 2016 7:00 am RNS Faron files patent application for Traumakine
10th Feb 2016 7:00 am RNS Notice of Preliminary Results
7th Jan 2016 7:00 am RNS Top-line results from Japanese study of Traumakine
29th Dec 2015 7:00 am RNS First Patient recruited in Phase III ARDS Study
FTSE 100 Latest
Value10,897.27
Change0.00